On July 10, the U.S. Food and Drug Administration approved Rexulti (brexpiprazole) tablets to treat adults with schizophrenia and as an add-on treatment to an antidepressant medication to treat adults with major depressive disorder (MDD).
Category Archives: Food Safety News
Maya Overseas Foods Inc. Recalls Cashew Split Because of Possible Health Risk
Maya Overseas Foods Inc. of Maspeth, NY, is recalling approximately 8000 lbs. of Cashew Split because it has the potential to be contaminated with Salmonella, an organism which can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems. Healthy persons infected with Salmonella often experience fever, diarrhea (which may be bloody), nausea, vomiting and abdominal pain.
Read The Complete Story!
FDA takes steps to prevent sales of unapproved kidney drugs for dogs and cats
On July 10, 2015, the United States District Court for the District of Nevada entered a consent decree of permanent injunction against Bio Health Solutions LLC, of Las Vegas and its manager and co-owner, Mark Garrison, for selling RenAvast, an unapproved animal drug.
Carnivore Meat Company, LLC Voluntarily Issues a Recall Two Batches of Raw Pet Treats
Carnivore Meat Company, LLC is recalling select products and lots of Carnivore Vital Essentials pet foods because they have the potential to be contaminated with Listeria monocytogenes. Healthy cats and dogs rarely become sick from Listeria monocytogenes. In humans, however, Listeria is an organism which can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems
Read The Complete Story!
FDA approves new drug to treat heart failure
The U.S. Food and Drug Administration today approved Entresto (sacubitril/valsartan) tablets for the treatment of heart failure. The drug has been shown to reduce the rate of cardiovascular death and hospitalization related to heart failure.
FDA approves new drug to treat heart failure
The U.S. Food and Drug Administration today approved Entresto (sacubitril/valsartan) tablets for the treatment of heart failure. The drug has been shown to reduce the rate of cardiovascular death and hospitalization related to heart failure.
Boulder Dog Food Company, L.L.C. Voluntarily Recalls Seven Bags of Turkey Sprinkles, 3 oz with A “Best By” Date of “05/18/16, 05/28/2016 and 05/30/2016” Due to Possible Salmonella Health Risk
Boulder Dog Food Company, L.L.C. is voluntarily recalling the Turkey Sprinkles (3 oz.) with a “Best By” date of “05/18/16, 05/28/2016 and 05/30/2016”, a Lot Number of “743”, and a UPC Code of 899883001224 because the product has the potential of being contaminated with Salmonella. Salmonella can affect animals eating the product, and there is risk to humans who handle the product, especially if the handler does not thoroughly wash his or her hands after having contact with the Product or any surfaces exposed to the product.
Read The Complete Story!
FDA approves new treatment for cystic fibrosis
The U.S. Food and Drug Administration today approved the first drug for cystic fibrosis directed at treating the cause of the disease in people who have two copies of a specific mutation.
Natural Grocers® issues recall on 10oz. Caribbean Nut & Fruit Mix due to possible health risk
Vitamin Cottage Natural Food Markets Inc., a Lakewood, Colo., based natural grocery chain, is recalling one lot of Natural Grocers brand Caribbean Nut & Fruit Mix as the product contains macadamia nuts that have the potential to be contaminated with Salmonella, an organism which can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems.
Read The Complete Story!
Federal judge enters permanent injunction against Acino Products, LLC
A federal judge for the District of New Jersey has entered a consent decree of permanent injunction between the United States and Acino Products LLC (Acino), of Hamilton, New Jersey, and the company’s president, Ravi Deshpande, for marketing unapproved and misbranded prescription drugs.